Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
JPMorgan Fundamental Data Science Mid Core ETF (MCDS) and NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) belong to the same industry segment: US Mid Cap. MCDS's top 3 sector exposures are Industrials, Information Technology and Financials. In contrast, IQSM's top sector exposures are Industrials, Information Technology and Health Care. MCDS is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.16% for IQSM. MCDS is up 0.53% year-to-date (YTD) with - in YTD flows. IQSM performs better with 1.9% YTD performance, and +$61M in YTD flows. Run a side-by-side ETF comparison of MCDS and IQSM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MCDS IQSM | -4.42%-4.41% | -0.26%+0.05% | +0.53%+1.90% | +14.39%+17.13% | n/a+39.89% | n/an/a |
| Flows | MCDS IQSM | -+$45M | -+$60M | -+$61M | +$32K+$44M | -+$219M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MCDS IQSM | +13.47%+14.56% | +19.14%+20.37% | n/a+17.45% | n/an/a |
| Max drawdown | MCDS IQSM | -6.28%-5.34% | -14.55%-15.27% | n/a-23.67% | n/an/a |
| Max drawdown duration | MCDS IQSM | 14d13d | 46d46d | n/a379d | n/an/a |
MCDS | IQSM | |
Last sale 3/13/2026 at 1:30 PM | $58.85 | $34.49 |
| Previous close 03/12/2026 | $58.84 | $34.57 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
MCDS | IQSM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
MCDS | IQSM | |
|---|---|---|
| Last price | $58.85 | $34.49 |
| 1D performance | +0.02% | -0.25% |
| AuM | $7.06 M | $270.02 M |
| E/R | 0.35% | 0.16% |
MCDS | IQSM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | J.P. Morgan Asset Management | New York Life Investments |
| Benchmark | - | NYLI Candriam U.S. Mid Cap Equity Index |
| N° of holdings | 174 | 219 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 7, 2024 | October 25, 2022 |
| ESG | No | Yes |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
